StimAire, a paradigm-shifting injectable neuromodulation company developing medical devices for obstructive sleep apnea (OSA), is pleased to be named Medtech Startup of the Year by Fluxx International on December 5, 2025.

“Fluxx Events is a platform celebrating innovation, leadership, and impact. We honor visionaries, changemakers, and trailblazers shaping the future with their remarkable achievements. The Healthcare and Wellness Elites honors individuals, organizations, and thought leaders advancing healthcare and wellness through innovation, leadership, and a commitment to improving lives. From groundbreaking medical technologies to promoting holistic health solutions, these leaders set the standard for excellence in their fields.” said Abhishek Narayan, Founder, Fluxx.

StimAire recently completed its first-in-human study of its groundbreaking injectable stimulator for OSA, marking a significant milestone in the company’s journey to provide innovative solutions for sleep disorders. StimAire has received Breakthrough Device Designation by the FDA, and our solution is featured in several technical and business publications.

https://www.youtube.com/watch?v=oRLh9PBW400&list=PLfFlggYXFQVG36SOLNNbpUQmfPRGPiwFC&index=4

Contact:
Tarek Makansi PhD
Founder and CTO
StimAire
tmakansi@stimaire.com
1-520-360-0823